Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

West Pharmaceutical Services, Inc. (WPS.F)

Compare
183.55
+14.60
+(8.64%)
At close: 8:18:23 AM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 748.8M
Earnings 130.1M

Q1'24

Q2'24

Q3'24

Q4'24

0
200M
400M
600M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1091211
Avg. Estimate 686.29M711.03M2.9B3.09B
Low Estimate 680M696M2.88B3.03B
High Estimate 700M741.4M2.94B3.17B
Year Ago Sales 695.4M702.1M2.89B2.9B
Sales Growth (year/est) -1.31%1.27%0.11%6.54%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
WPS.F --------
S&P 500 6.43%6.13%9.43%14.26%

Upgrades & Downgrades

Initiated Evercore ISI Group: Outperform 3/18/2025
Maintains Keybanc: Overweight to Overweight 2/14/2025
Initiated Citigroup: Buy 1/8/2025
Maintains B of A Securities: Buy to Buy 12/13/2024
Initiated Wolfe Research: Peer Perform 12/13/2024
Upgrade UBS: Neutral to Buy 12/12/2024